Q BioMed Inc. Announces Mannin Research Accepted Into Johnson & Johnson Innovation, JLABS @ Toronto Biotech Investing
Vitality Biopharma Publishes Scientific Data on Discovery of Cannabinoid Glycosides Biotech Investing
Trillium Therapeutics Doses First Patient With TTI-621 in Phase 1 Solid Tumor Trial Biotech Investing
Cellectar Biosciences Demonstrates Capabilities of the PDC Platform in Two Peer Reviewed Studies Biotech Investing
Incyte and Calithera Biosciences Announce Global Collaboration to Develop and Commercialize CB-1158, a First-in-class, Small Molecule Arginase Inhibitor Biotech Investing
